Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

S.Korea's Celltrion says COVID-19 drug shows 100-fold reduction in viral load

SEOUL, June 1 (Reuters) - South Korea's Celltrion Inc
 068270.KS  said on Monday its experimental treatment of
COVID-19 demonstrated a 100-fold reduction in viral load of the
disease in animal testing. 
    The pharmaceutical company said the first in-human clinical
trials of the treatment are set to start in July. 

 (Reporting by Joyce Lee; Editing by Himani Sarkar)
 ((jungyoon.lee@tr.com; +82 2 6936 1467;))

Recent news on Celltrion Healthcare Co

See all news